Fundz

Lumos Pharma, Inc. reported raising $34 Million in an initial SEC Form D filing, from an offering of $34 Million

PRIVATEApr 18, 2016

Amount Raised

$34 Million

$34 Million sold, per SEC Form D (first sale Apr 18, 2016)

Round Type

Venture

AustinBiotechnology

Quick answer

Lumos Pharma, Inc. raised $34 Million in a funding round, dated April 18, 2016. Lumos Pharma, Inc. is based in Austin, Texas, United States.

How much did Lumos Pharma, Inc. raise?
Lumos Pharma, Inc. raised $34 Million in a funding round on April 18, 2016.
What does Lumos Pharma, Inc. do?
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases.
Where is Lumos Pharma, Inc. based and how big is it?
Lumos Pharma, Inc. is based in Austin, Texas, United States.
Who are the decision-makers at Lumos Pharma, Inc?
Fundz holds 1 contact at Lumos Pharma, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lumos Pharma, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • GARWOOD MEDICAL DEVICES raised $2M (Seed) on June 2, 2016.
  • Arch Therapeutics raised $3.4M (Seed) on June 2, 2016.
  • Cytobyte, Inc. raised an undisclosed amount on June 2, 2016.
  • Ana Bios raised $5.1M on June 1, 2016.
  • Harvard Apparatus Regenerative Technology raised $5M on June 1, 2016.
  • Scythian Biosciences Inc. raised $170K (Pre-Seed) on May 31, 2016.

Who to call at Lumos Pharma, Inc., and when

A new round usually means Lumos Pharma, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lumos Pharma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lumos Pharma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lumos Pharma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lumos Pharma, Inc.

Location

4200 Marathon Blvd., Suite 200

Austin, Texas, United States

About

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. The Company was founded and is led by a management team with longstanding experience in rare disease drug development. Lumos Pharma’s lead therapeutic candidate, LUM-201, is a novel, oral growth hormone (GH) secretagogue, seeking to transform the ~$3.4B global GH market from injectable to oral therapy. LUM-201 is currently being evaluated in multiple Phase 2 clinical studies in Pediatric Growth Hormone Deficiency (PGHD) and has received Orphan Drug Designation in both the US and EU.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lumos Pharma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Lumos Pharma, Inc.'s next move

See what Strategic adds

Lumos Pharma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.